317 related articles for article (PubMed ID: 32340161)
21. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
22. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
[TBL] [Abstract][Full Text] [Related]
23. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.
Jørgensen AS; Brandum EP; Mikkelsen JM; Orfin KA; Boilesen DR; Egerod KL; Moussouras NA; Vilhardt F; Kalinski P; Basse P; Chen YH; Yang Z; Dwinell MB; Volkman BF; Veldkamp CT; Holst PJ; Lahl K; Goth CK; Rosenkilde MM; Hjortø GM
Cell Mol Life Sci; 2021 Nov; 78(21-22):6963-6978. PubMed ID: 34586443
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic Metastasis of NSCLC Involves Chemotaxis Effects of Lymphatic Endothelial Cells through the CCR7-CCL21 Axis Modulated by TNF-α.
Zhang S; Wang H; Xu Z; Bai Y; Xu L
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33158173
[TBL] [Abstract][Full Text] [Related]
25. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
[TBL] [Abstract][Full Text] [Related]
26. The Important Role of the Chemokine Axis CCR7-CCL19 and CCR7-CCL21 in the Pathophysiology of the Immuno-inflammatory Response in Dry Eye Disease.
Wang T; Li W; Cheng H; Zhong L; Deng J; Ling S
Ocul Immunol Inflamm; 2021 Feb; 29(2):266-277. PubMed ID: 31702421
[No Abstract] [Full Text] [Related]
27. CCL21/CCR7 axis as a therapeutic target for autoimmune diseases.
Han L; Zhang L
Int Immunopharmacol; 2023 Aug; 121():110431. PubMed ID: 37331295
[TBL] [Abstract][Full Text] [Related]
28. CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma.
Li F; Zou Z; Suo N; Zhang Z; Wan F; Zhong G; Qu Y; Ntaka KS; Tian H
Med Oncol; 2014 Sep; 31(9):180. PubMed ID: 25142946
[TBL] [Abstract][Full Text] [Related]
29. Association of chemokine and chemokine receptor expression with the invasion and metastasis of lung carcinoma.
Liu Y; Wu BQ; Geng H; Xu ML; Zhong HH
Oncol Lett; 2015 Sep; 10(3):1315-1322. PubMed ID: 26622670
[TBL] [Abstract][Full Text] [Related]
30. NMR indicates the N-termini of PSGL1 and CCR7 bind competitively to the chemokine CCL21.
Witt RN; Nickel KS; Binns JR; Gray AM; Hintz AM; Kofron NF; Steigleder SF; Peterson FC; Veldkamp CT
Biochem Biophys Rep; 2023 Sep; 35():101524. PubMed ID: 37554427
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
[TBL] [Abstract][Full Text] [Related]
32. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.
Oliveira-Neto HH; de Souza PP; da Silva MR; Mendonça EF; Silva TA; Batista AC
Tumour Biol; 2013 Feb; 34(1):65-70. PubMed ID: 22976543
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21.
Lee J; Park C; Kim HJ; Lee YD; Lee ZH; Song YW; Kim HH
Exp Mol Med; 2017 Jul; 49(7):e358. PubMed ID: 28729639
[TBL] [Abstract][Full Text] [Related]
34. CCR7 as a therapeutic target in Cancer.
Salem A; Alotaibi M; Mroueh R; Basheer HA; Afarinkia K
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188499. PubMed ID: 33385485
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation.
Maolake A; Izumi K; Natsagdorj A; Iwamoto H; Kadomoto S; Makino T; Naito R; Shigehara K; Kadono Y; Hiratsuka K; Wufuer G; Nastiuk KL; Mizokami A
Cancer Sci; 2018 May; 109(5):1524-1531. PubMed ID: 29575464
[TBL] [Abstract][Full Text] [Related]
37. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis.
Banas B; Wörnle M; Berger T; Nelson PJ; Cohen CD; Kretzler M; Pfirstinger J; Mack M; Lipp M; Gröne HJ; Schlöndorff D
J Immunol; 2002 May; 168(9):4301-7. PubMed ID: 11970971
[TBL] [Abstract][Full Text] [Related]
38. A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system.
Comerford I; Harata-Lee Y; Bunting MD; Gregor C; Kara EE; McColl SR
Cytokine Growth Factor Rev; 2013 Jun; 24(3):269-83. PubMed ID: 23587803
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.
Cassier PA; Treilleux I; Bachelot T; Ray-Coquard I; Bendriss-Vermare N; Ménétrier-Caux C; Trédan O; Goddard-Léon S; Pin JJ; Mignotte H; Bathélémy-Dubois C; Caux C; Lebecque S; Blay JY
BMC Cancer; 2011 May; 11():213. PubMed ID: 21624121
[TBL] [Abstract][Full Text] [Related]
40. A Novel Computational Model Predicts Key Regulators of Chemokine Gradient Formation in Lymph Nodes and Site-Specific Roles for CCL19 and ACKR4.
Jafarnejad M; Zawieja DC; Brook BS; Nibbs RJB; Moore JE
J Immunol; 2017 Oct; 199(7):2291-2304. PubMed ID: 28807994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
